Resalis Therapeutics

Description: Resalis Therapeutics develops antisense therapies for metabolic disorders like NAFLD, NASH, and obesity, with lead candidate RES 010 targeting key pathways.

Country: Italy

Based in: Turin

Founded: 2021

Funding Stage: Pre-Seed

Tags: ['Content Management System', 'Email Hosting Service', 'Email Hosting Service', '']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.